904 related articles for article (PubMed ID: 27883002)
1. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
[TBL] [Abstract][Full Text] [Related]
2. A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD.
van der Palen J; Moeskops-van Beurden W; Dawson CM; James WY; Preece A; Midwinter D; Barnes N; Sharma R
Int J Chron Obstruct Pulmon Dis; 2018; 13():2515-2523. PubMed ID: 30174421
[TBL] [Abstract][Full Text] [Related]
3. A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
van der Palen J; Slade D; Rehal S; Verma M; Plank M
Respir Med; 2022 Dec; 205():107031. PubMed ID: 36368290
[TBL] [Abstract][Full Text] [Related]
4. First-time handling of different inhalers by chronic obstructive lung disease patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
[No Abstract] [Full Text] [Related]
5. Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
Chrystyn H; Price DB; Molimard M; Haughney J; Bosnic-Anticevich S; Lavorini F; Efthimiou J; Shan D; Sims E; Burden A; Hutton C; Roche N
BMC Pulm Med; 2016 Jan; 16():12. PubMed ID: 26769482
[TBL] [Abstract][Full Text] [Related]
6. ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
Kerwin EM; Preece A; Brintziki D; Collison KA; Sharma R
J Allergy Clin Immunol Pract; 2019; 7(6):1843-1849. PubMed ID: 30836228
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
von Schantz S; Katajavuori N; Antikainen O; Juppo A
Int J Pharm; 2016 Jul; 509(1-2):50-58. PubMed ID: 27208655
[TBL] [Abstract][Full Text] [Related]
8. Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.
Collier DJ; Wielders P; van der Palen J; Heyes L; Midwinter D; Collison K; Preece A; Barnes N; Sharma R
Int J Chron Obstruct Pulmon Dis; 2020; 15():1301-1313. PubMed ID: 32606640
[TBL] [Abstract][Full Text] [Related]
9. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients.
Jang JG; Chung JH; Shin KC; Jin HJ; Lee KH; Ahn JH
Int J Chron Obstruct Pulmon Dis; 2021; 16():1051-1059. PubMed ID: 33907392
[TBL] [Abstract][Full Text] [Related]
10. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
Yun Kirby S; Zhu CQ; Kerwin EM; Stanford RH; Georges G
COPD; 2016; 13(2):167-75. PubMed ID: 26516724
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of errors in inhaler technique among COPD versus asthma patients.
Ocakli B; Ozmen I; Tunçay EA; Gungor S; Altinoz H; Adiguzel N; Sak ZA; Gungor G; Karakurt Z; Arbak P
Int J Chron Obstruct Pulmon Dis; 2018; 13():2941-2947. PubMed ID: 30288037
[TBL] [Abstract][Full Text] [Related]
12. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
13. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
[TBL] [Abstract][Full Text] [Related]
14. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
[TBL] [Abstract][Full Text] [Related]
15. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
[TBL] [Abstract][Full Text] [Related]
16. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
17. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
Serra-Batlles J; Plaza V; Badiola C; Morejón E;
J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
[TBL] [Abstract][Full Text] [Related]
18. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
[TBL] [Abstract][Full Text] [Related]
19. ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
Kerwin EM; Spangenthal S; Zvarich M; Millar V; Jain R; Collison K; Sharma R
Chronic Obstr Pulm Dis; 2020 Apr; 7(2):118-129. PubMed ID: 32324983
[TBL] [Abstract][Full Text] [Related]
20. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD.
Schulte M; Osseiran K; Betz R; Wencker M; Brand P; Meyer T; Haidl P
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):321-8. PubMed ID: 18823257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
